Indications and limitations for aged patients with chronic hepatitis C in pegylated interferon alfa-2b plus ribavirin combination therapy (Q43031896)

From Wikidata
Jump to navigation Jump to search
scientific article published on 9 December 2010
edit
Language Label Description Also known as
English
Indications and limitations for aged patients with chronic hepatitis C in pegylated interferon alfa-2b plus ribavirin combination therapy
scientific article published on 9 December 2010

    Statements

    Indications and limitations for aged patients with chronic hepatitis C in pegylated interferon alfa-2b plus ribavirin combination therapy (English)
    Tsugiko Oze
    Naoki Hiramatsu
    Takayuki Yakushijin
    Kiyoshi Mochizuki
    Masahide Oshita
    Hideki Hagiwara
    Eiji Mita
    Toshifumi Ito
    Hiroyuki Fukui
    Yoshiaki Inui
    Taizo Hijioka
    Masami Inada
    Kazuhiro Kaytayama
    Shinji Tamura
    Harumasa Yoshihara
    Atsuo Inoue
    Yasuharu Imai
    Michio Kato
    Takuya Miyagi
    Yuichi Yoshida
    Tomohide Tatsumi
    Shinichi Kiso
    Tatsuya Kanto
    Akinori Kasahara
    Tetsuo Takehara
    Norio Hayashi
    9 December 2010
    604-611

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit